Stem Cell Convention Market Analysis and Reports | Japan Conference Series

Market Analysis - Stem Cell Convention-2017

10th World Congress on Stem Cell and Biobanking

Success of the 9 Cell Science conferences series has given us the prospect to bring the gathering one more time for our 10th World Congress 2017 meet in October 23-24, 2017 Osaka, Japan. Since its commencement in 2011 cell science series has perceived around 750 researchers of great potentials and outstanding research presentations around the globe. The awareness of stem cells and its application is increasing among the general population that also in parallel offers hope and add woes to the researchers of cell science due to the potential limitations experienced in the real-time. 

Stem Cell and Biobanking-2017 has the goal to fill the prevailing gaps in the transformation of this science of hope to promptly serve solutions to all in the need. Stem cell and Biobanking-2017 will have an anticipated participation of 100-120 delegates from around the world to discuss the conference goal. 

History of Stem cells Research        

Stem cells have an interesting history; in the mid-1800s it was revealed that cells were basically the building blocks of life and that some cells had the ability to produce other cells. Efforts were made to fertilize mammalian eggs outside of the human body and in the early 1900s, it was discovered that some cells had the capacity to generate blood cells. In 1968, the first bone marrow transplant was achieved successfully to treat two siblings with severe combined immunodeficiency. Other significant events in stem cell research include:

1978: Stem cells were discovered in human cord blood
1981: First in vitro stem cell line developed from mice
1988: Embryonic stem cell lines created from a hamster
1995: First embryonic stem cell line derived from a primate
1997: Cloned lamb from stem cells
1997: Leukemia origin found as haematopoietic stem cell, indicating possible proof of cancer stem cells

Funding in USA:

No federal law forever did embargo stem cell research in the United States, but only placed restrictions on funding and use, under Congress's power to spend. By executive order on March 9, 2009, President Barack Obama removed certain restrictions on federal funding for research involving new lines of human embryonic stem cells. Prior to President Obama's executive order, federal funding was limited to non-embryonic stem cell research and embryonic stem cell research based upon embryonic stem cell lines in existence prior to August 9, 2001. In 2011, a United States District Court "threw out a lawsuit that challenged the use of federal funds for embryonic stem cell research”.

Members Associated with Stem Cell Research:

     Discussion on Development, Regeneration, and Stem Cell Biology takes an interdisciplinary approach to understanding the fundamental question of how a single cell, the fertilized egg, ultimately produces a complex fully patterned adult organism, as well as the intimately related question of how adult structures regenerate. Stem cells play critical roles both during embryonic development and in later renewal and repair. More than 65 faculties in Philadelphia from both basic science and clinical departments in the Division of Biological Sciences belong to Development, Regeneration, and Stem Cell Biology. Their research uses traditional model species including nematode worms, fruit-flies, Arabidopsis, zebrafish, amphibians, chick and mouse as well as non-traditional model systems such as lampreys and cephalopods. Areas of research focus include stem cell biology, regeneration, developmental genetics, and cellular basis of development, developmental neurobiology, and “evo-devo” (Evolutionary developmental biology).

Stem Cell Market Value:

Worldwide many companies are developing and marketing specialized cell culture media, cell separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Stem Cell Therapy Market, By Region, 2009 2018




Why to attend???

Stem Cell Research-2017 could be an outstanding event that brings along a novel and International mixture of researchers, doctors, leading universities and stem cell analysis establishments creating the conference an ideal platform to share knowledge, adoptive collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in cell science fields are assurances of this conference. 

A Unique Opportunity for Advertisers and Sponsors at this International event:

UAS Major Universities which deals with Stem Cell Research 

·  University of Washington/Hutchinson Cancer Center

·  Oregon Stem Cell Center

·  University of  California Davis

·  University of  California San Francisco

·  University of California Berkeley

·  Stanford University

·   Mayo Clinic

Major Stem Cell Organization Worldwide:

·  Norwegian Center for Stem Cell Research

·  France I-stem

·  Stem Cell & Regenerative Medicine Ctr, Beijing

·  Stem Cell Research Centre, Korea

·  NSW Stem Cell Network

·  Monash University of  Stem Cell Labs

·  Australian Stem Cell Centre

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience

Market Analysis of Stem Cell Therapy:

The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018

 Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

Figure 2: Global Market

Companies working for Stem Cells:



Business Type

Cynata Therapeutics

Armadale, Australia

Stem Cell Manufacturing Technology


Melbourne, Australia

Regenerative Medicine


Vienna, Austria

Dendritic Cell-Based Cancer Immunotherapy


Vienna, Austria

Treatments composed of mixture of cytokines, growth factors and other active components

Cardio3 Biosciences

Mont-Saint-Guibert, Belgium

Stem Cell Differentiation

Orthocyte (BioTime)

Alameda, CA

Cellular Therapies


Beverly Hills, CA

Stem Cell Heart Treatments

Life Stem Genetics

Beverly Hills, CA

Autologous stem cell therapy

International Stem Cell

Carlsbad, CA

Proprietary Stem Cell Induction


Carlsbad, CA

Cell Therapy

DaVinci Biosciences

Costa Mesa, CA

Cellular Therapies

Invitrx Therapeutics

Irvine, CA

Autologous Stem Cell Therapy, Therapeutic & Cosmetic



Stem Cell Software’s :

  1. Cryus : Cryus is developed specially for Cord Blood Banks, Donor Centers, Stem Cells Collection Centers, Biotech Laboratories and Tissue Banks.
  2. Label-InnThe: Which allows to record the donor or the patient personal data into the database and generates the Donation Identification Number (DIN) according to ICCBBA international standard ISBT128. It serves as labelling software for blood samples and Stem Cells products.

Products Manufactured By Industry Related to Stem Cell:

RoboSep™-16 is the latest RoboSep™ instrument ingenuous for performing fully-automated cell separation from a huge number of samples. Using EasySep™, the column-free immunomagnetic cell separation system, RoboSep™-16 isolates desired cells from a wide range of samples from different species, tissue sources or sizes using positive or negative selection. Through an intuitive user interface, the RoboSep™-16 simultaneously isolates cells from up to sixteen samples with minimal hands on time. By automating all reagent and sample handling steps, and through the use of disposable pipette tips, the RoboSep™-16 rapidly isolates all desired cells while minimizing the risk of sample cross-contamination. After completion of the cell isolation procedure, cells of interest are immediately available for any downstream application.

The EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit is designed to isolate highly purified CD25+ cells from single cell suspensions of splenocytes or other tissues by positive selection. Desired cells are labeled with antibodies and magnetic particles.  The cells are separated without columns using an EasySep™ magnet.  Unwanted cells are simply poured off, while desired cells remain in the tube.  Isolated cells are immediately ready for downstream applications such as flow cytometry, cell culture, or suppression assays.

Featured Research:

       Gene therapy gives assurance for severe combined immunodeficiency, Researchers have initiated that gene therapy using a improved delivery system, or vector, can restore the immune systems of children with X-linked severe combined immunodeficiency (SCID-X1), a rare, life-threatening inherited condition that primarily affects boys. Previous efforts to treat SCID-X1 with gene therapy were initially efficacious, but approximately one-quarter of the children developed leukemia two to five years after treatment. Results from a study partially funded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that the new vector is equally effective at restoring immunity and may be safer than previous approaches.



Hear, Explore and learn the latest research. Present before distinguished global audience. Collaborate, build partnerships and experience Japan. Join the global academic community.
Conferenceseries LLC invites all the participants across the globe to attend the 10th World Congress on Stem Cell and Biobanking October 23-24, 2017 Osaka, Japan. Stem Cell and Biobanking 2017 includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Stem Cell and Biobanking 2017 aims in proclaim knowledge and share new ideas amongst the professionals, industrialists and students from research area of Stem Cell and Biobanking to share their research experiences and indulge in interactive discussions at the event. This scientific gathering guarantees that offering the thoughts and ideas will enable and secure you the theme “Accelerating Innovative Research &Technology in Stem Cell & Biobanking”. Stem Cell and Biobanking is the latest trending research in many fields especially in Organ cancer: breast, oral, head and neck Cancer Myeloid, lymphoid leukaemia’s, cancer treatments etc. The current era fully rolled out with many new advanced treatment technologies. In such case more Stem Cell research institutes were newly introduced within market which obviously shows the market growth of Stem Cell and Biobanking. While analysing the revenue growth of Stem Cell and Biobanking functions, it highly developed from $150 billion USD to $250 billion USD since from 2010-2015. And the annual growth percentage increases from 20-55 percentages. 
Importance and Scope:
Recently, there has been an increasing demand for quality and trained manpower in this evolving branch of biomedicine. As a result of this, stem cell research is emerging as a rage among the many career options available to people in associated fields. The current investment in stem cell research in India is more than 1000 crores. Most of the investment in stem cell research in India is in the government sector. So there are a lot of research opportunities on a national front in India. 
Why to attend?
With members from around the world focused on learning about Stem Cell and Biobanking, this is your single best opportunity to reach the largest assemblage of participants from the Stem cell research community. Conduct demonstrations, distribute information, acquire knowledge about current and trending Stem cell and Biobanking technologies, make a splash with a new research, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields are hallmarks of this conference.
Target Audience:
 Head of the Departments from the field of Biological sciences, Genetics, Regenerative medicine, Oncology…
Doctors from the fields of Oncology, surgery, organ transplantation, infertility, Clinical Trails
Stem cell and Biobanking Lab Directors/Associates
Stem cell researchers and academicians
Doctorates in Bio- Sciences
Professors and Students from Academia in the study of Stem cell and Biobanking research
Regenerative medicine Lab Directors/Associates
Professors of Life sciences  
Conference Highlights
·         Stem Cells Biology
·         Stem Cell technology
·         Stem Cell Therapy Research
·         Epigenetics
·         Stem cell apoptosis and signal transduction
·         Regenerative Medicine
·         Tissue Regeneration
·         Next Generation Bio-banking
·         Stem cell biomarkers
·         Cell & Organ Regeneration
·         Stem cell niches
·         Fertility Biobanks
·         Biobank Ethics
·         Market Analysis in Biobanking
·         Next Generation Biobanking 
Special Issues:
All accepted abstracts will be published in respective International Journals.
Abstracts will be provided with Digital Object Identifier by Cross Ref.